Chronic Wound Care, Third Edition “Highly Recommended” by NADONA
The National Association of Directors of Nursing Administration (NADONA) recently reviewed Chronic Wound Care: A Clinical Source Book for Healthcare Professionals, Third Edition (CWC), and highly recommended it to DONs. NADONA’s review was published in the Vol. 10, No. 1, 2002, edition of its official newsletter, The Director. The review describes CWC as, “the most comprehensive text available to those involved in care of patients afflicted with skin and wound problems. An outstanding value, a must for the DON’s library. Highly recommended by NADONA.” CWC, published by HMP Communications, is edited by Drs. Diane Krasner, George Rodeheaver, and Gary Sibbald. This instructive book contains 71 chapters by 110 contributors from around the world and is 782 pages in length. Each chapter begins with objectives and a case vignette and concludes with a case vignette wrap-up and questions with answers. The book also includes a foreword, an introductory chapter on advanced wound healing by the editors, and a conclusion. CWC is an ideal teaching tool for groups or individuals, and contains a full-color section of demonstrative clinical photographs. For a complete brochure or to place an order, contact HMP at: Phone (800) 237-7285 or (610) 560-0500, ext. 221, Fax (610) 560-0501, HMP Communications, 83 General Warren Blvd, Suite 100, Malvern, PA 19355, www.hmpcommunications.com. Available in hard bound ($99.95) and soft bound ($79.95).

Polyheal Initiates Wound Healing Clinical Study for Treatment of Ulcers in Diabetic Patients
Polyheal Ltd. announced initiation of a clinical study of Polyheal 1 for the treatment of chronic foot ulcers in diabetic neuropathic patients. It is anticipated that the treatment using Polyheal 1 will prove the device’s safety, reduce the healing time, and increase the healing rate of these ulcers in comparison to current therapies. The multicenter, double-blinded study is expected to enroll 60 patients with diabetic neuropathic foot ulcers. The study includes three arms: patients will be treated with one of two regimens of Polyheal 1 or with a placebo. Patients will receive the device therapy for up to 12 weeks in out-patient clinics. Clinical data regarding the device’s safety as well as its efficacy will be measured by the length of time to wound closure. Polyheal 1 is a device that consists of synthetic microspheres suspended in an aqueous nutrient medium. The device is capable of forming multipoint contact with the cellular membrane and promotes the complex process of wound healing. The device was discovered and developed using Polyheal’s core proprietary technology for using synthetic microspheres to induce and facilitate wound healing and tissue regeneration. The technology works without the addition of any pharmacologically active material. For more information visit www.polyheal.co.il or contact: Dr. Menachem Ze’evi, Chief Executive Officer, Phone 011-972-4-820-7917, Fax: 011-972-4-820-7919.

Regent Medical to Market Leading Antiseptic Solutions
Regent Medical recently acquired HIBICLENS® brand of antiseptic/antimicrobial skin cleansers. HIBICLENS contains chlorhexidine gluconate and is an effective antimicrobial agent with rapid bactericidal activity against a wide range of microorganisms, including gram-positive and gram-negative bacteria. HIBICLENS can be used many times a day without causing dryness or discomfort. Indications for use include surgical hand scrub, preoperative whole body wash, and general skin cleansers. For more information, call (800) 843-8497.

The ROHO Group Introduces the Quadtro® Select Cushion
The Quadtro Select Cushion with Isoflo™ Control by The ROHO Group is an innovative progressive positioning system designed to provide exceptional stability and adjustment capabilities to the clinician and the user.